Press Room
Press Room
Please direct all press inquiries to [email protected]

Our experts are available to comment on a range of global health issues, including pandemic prevention, preparedness, and response; health financing; access to medicines; supply chain management; maternal and child health; tuberculosis, malaria, HIV and AIDS; public health leadership; vaccines; and more. We offer expertise in English, French, and Spanish. Browse our press statements and stories below for our latest news.
Featured Stories
MSH’s Dr. Justice Nonvignon Named Director for Africa, International Health Economics Association’s Board of Directors
Arlington, VA—December 11, 2025—MSH congratulates Justice Nonvignon, PhD, who leads our health economics and financing practice area, for his appointm…
How Ukraine’s Digital Transformation Is Strengthening Its Health Supply Chain and Protecting Patient Access
Ukrainians Share Their Stories of Living with HIV: A National Campaign Expands Access to Information and Free Treatment Services
About Us
Since our founding in 1971, we’ve completed hundreds of projects in more than 150 countries. We are currently implementing more than 40 projects and providing support to 35-plus countries worldwide. The majority of our 980+ staff members are located outside the US, and 73% of them work in the countries they are originally from.
Our work spans pandemic prevention, preparedness, and response; health financing; access to medicines; supply chain management; maternal and child health; tuberculosis, malaria, HIV and AIDS; public health leadership; vaccines; and more.
Our donors include governments and international agencies, such as the United States Agency for International Development (USAID), the US Centers for Disease Control and Prevention (CDC), the Global Fund to Fight AIDS, Malaria and Tuberculosis; foundations and corporations, including the Bill & Melinda Gates Foundation, Margaret A. Cargill Philanthropies, John D. and Catherine T. MacArthur Foundation, The James M. & Cathleen D. Stone Foundation, Novartis, Merck, Pfizer, Roche; and individuals. See a complete list of our donors here.
Our partners range from large international NGOs to small, community-led local organizations in the countries where we work. We also partner with governments, academic institutions, and faith-based organizations.




